Quick Answer
Zura Bio Ltd reported Research And Development Expense of $42.08 million for the year ending 2025.
- Zura Bio Ltd showed an increase of +72.5% in Research And Development Expense from 2024 to 2025.
- This data is from Zura Bio Ltd's annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $7.50 million | Q2 2022: $85.0 thousand | Q3 2022: $415.0 thousand | Q1 2023: $4.88 million | Q2 2023: $28.23 million | Q3 2023: $3.97 million | Q1 2024: $3.59 million | Q2 2024: $5.54 million | Q3 2024: $6.03 million | Q1 2025: $10.47 million | Q2 2025: $8.70 million | Q3 2025: $11.95 million.
- Over the full 4 years of available data (2022 to 2025), Zura Bio Ltd's Research And Development Expense has grown by 77.6%.
- Historical annual values: Fiscal year 2025: $42.08 million | Fiscal year 2024: $24.40 million | Fiscal year 2023: $44.00 million | Fiscal year 2022: $23.69 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: